Navigation Links
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
Date:6/29/2009

FRANKLIN LAKES, N.J., June 29 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2009 earnings conference call on Thursday, July 30, 2009 at 10:00 a.m. (EDT). BD will issue a press release detailing the quarter's earnings earlier that morning.

The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for replay through Thursday, August 6, 2009.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 counties throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

    Contact Information:
    Patricia A. Spinella, Investor Relations - 201-847-5453
    Colleen T. White, Corporate Communications - 201-847-5369


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 BioTrends Research ... advisory firms for specialized biopharmaceutical issues, finds that, ... infectious disease specialists reported that in the past ... intentionally delaying treatment) in anticipation of the next ... months ago, when only 6 percent reported that ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
(Date:5/23/2013)... SynCardia Systems, Inc. ( http://www.syncardia.com ), ... Canada and CE (Europe) approved Total Artificial Heart, announced ... boasts more than 380,000 visitors annually, is featuring the ... the Freedom® portable driver as part of its $3 ... of its kind. , “BodyWorks combines the latest ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... announced,today that it has sold T-COTE, its proprietary ... sale, Sensient assumes all marketing and,sales responsibilities and ... will remain involved during the transition for,technical support. ... to the product,its specifications or method and location ...
... Imaging,Diagnostic Systems, Inc., (OTC Bulletin Board: IMDS) ... announced today that its distributor,The Oyamo group has ... Mammography,System (CTLM(R)) for Jerusalem, Israel., (Logo: ... the import license from the Israel Ministry of,Health ...
... patients and caregivers from around the ... world ... GBS/CIDP Foundation,International will host its tenth international symposium on Guillain-Barre,Syndrome ... November 7-9, 2008. Over 250 medical professionals,current and former patients ...
Cached Biology Technology:Particle Sciences sells T-COTE(R) Line of Microfine Titanium Dioxides to Sensient 2Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel 2GBS/CIDP Foundation to Hold 10th International Symposium 2
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
(Date:5/23/2013)... Tomatoes, said to be the world,s most popular fruit, ... UK research with purple GM varieties. , "Working ... only by the addition of a specific compound, allows ... traits," said Professor Cathie Martin from the John Innes ... varieties with better flavour, health and shelf life characteristics ...
(Date:5/23/2013)... estrogen suppresses lipid synthesis in the liver, UC Irvine ... certain liver diseases. , With this finding, Dr. ... views in the field. Study results appear in the ... . , "The dogma in the steroid receptor field ... in the nucleus respond to steroid hormones by regulating ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... is a rare, devastating illness in which nerve cells that ... it, Lou Gehrigs disease or ALS (amyotrophic lateral sclerosis), is ... Hawking and Morrie Schwartz, about whom Mitch Alboms Tuesdays with ... cause is unknown. Figuring out why these people develop the ...
... March 3, 2008 On the evening of ... activities celebrating science and the spirit of discovery, nine ... two will be presented with prestigious Bower Awards. ... Nobel Prize, are awarded for outstanding achievements that have ...
... Research Awards were announced yesterday at an awards ceremony ... attended by shortlisted authors, eminent researchers from around the ... Research Awards, now in their second year, recognize excellence ... open access publication. The Awards celebrate the best medical ...
Cached Biology News:Motor neuron disease and toxic substances: Possible link? 2Motor neuron disease and toxic substances: Possible link? 3Science and technology take center stage this election year 2Science and technology take center stage this election year 3Science and technology take center stage this election year 4Science and technology take center stage this election year 5Science and technology take center stage this election year 6Excellence in open access research celebrated at BioMed Central awards dinner 2
... the needs of the biopharmaceutical ... supports fast cell growth rates ... maintaining high cell viability and ... the Baculovirus Expression Vector System ...
... number is a new ... easily match Cornings product ... availability yet, please order ... number (Z36,327-8) or contact ...
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
Biology Products: